JCR Pharmaceuticals Co., Ltd. announced that its Board of Directors resolved at a meeting held on April 25, 2024 change personnel change as follows: Change of Corporate Officer (As of June 26, 2024). The new title of Anne Bechet is Senior Corporate Officer, Executive Director, Clinical Development, General Manager, JCR Europe B.V., Director, JCR Luxemburg S. A and CEO, JCR USA Inc. Current Title is Clinical Development (Acting Officer), General Manager, JCR Europe B.V. and Director, JCR Luxemburg S.A.